Short Interest in Nuwellis, Inc. (NASDAQ:NUWE) Decreases By 21.3%

Nuwellis, Inc. (NASDAQ:NUWE) was the recipient of a significant drop in short interest during the month of February. As of February 28th, there was short interest totalling 207,800 shares, a drop of 21.3% from the February 13th total of 264,200 shares. Based on an average trading volume of 516,100 shares, the short-interest ratio is currently 0.4 days. Approximately 4.8% of the company’s shares are sold short.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Nuwellis stock. Geode Capital Management LLC acquired a new position in Nuwellis, Inc. (NASDAQ:NUWE) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 30,806 shares of the company’s stock, valued at approximately $34,000. Geode Capital Management LLC owned 0.70% of Nuwellis at the end of the most recent reporting period. Institutional investors and hedge funds own 3.13% of the company’s stock.

Nuwellis Stock Performance

Shares of NASDAQ:NUWE traded down $0.05 during mid-day trading on Tuesday, reaching $1.11. 53,910 shares of the company’s stock were exchanged, compared to its average volume of 999,654. Nuwellis has a twelve month low of $0.92 and a twelve month high of $16.63. The firm has a market capitalization of $4.86 million, a price-to-earnings ratio of -0.01 and a beta of 0.36. The business’s fifty day moving average price is $1.21 and its 200-day moving average price is $1.33.

About Nuwellis

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.